We’re seeking individuals aged 40 to 60 with stage 3 or 4 periodontitis to participate in a Melbourne-based clinical trial.
Help us test a promising vaccine administered over a 2-month period that could revolutionize periodontal disease treatment.
Learn more: contact Nucleus Network on 1800 243 733 or online: https://www.nucleusnetwork.com/au/form/4827631/